Score Overview
Explore the 2021 public Archive ranking →
Where Trinity Biotech plc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- TRIB
2006: 36.2% · 2021: 88.3% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 6.72 | — |
1 Year2025-09-26 | $ 32.10 | -79.07% |
5 Years2021-09-28 | $ 322.50 | -97.92% |
10 Years2016-09-28 | $ 1.95K | -99.66% |
20 Years2006-09-28 | $ 1.3K | -99.48% |
30 Years1996-09-27 | $ 1.88K | -99.64% |
All Time1995-08-18 | $ 1.35K | -99.50% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1995-08-18 |
|---|---|---|---|---|---|---|---|
| Price | $ 6.72 | $ 32.10 | $ 322.50 | $ 1.95K | $ 1.3K | $ 1.88K | $ 1.35K |
| Return | — | -79.07% | -97.92% | -99.66% | -99.48% | -99.64% | -99.50% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 52M | -$ 35M | $ 1M |
| 2024 | $ 61M | -$ 31M | $ 5M |
| 2023 | $ 56M | -$ 24M | $ 3M |
| 2022 | $ 62M | -$ 41M | $ 6M |
| 2021 | $ 81M | $ 875K | $ 25M |
| 2020 | $ 101M | -$ 6M | $ 27M |
| 2019 | $ 90M | -$ 4M | $ 16M |
| 2018 | $ 97M | $ 2M | $ 30M |
| 2017 | $ 99M | -$ 40M | $ 57M |
| 2016 | $ 99M | -$ 100M | $ 77M |
| 2015 | $ 100M | $ 21M | $ 101M |
| 2014 | $ 104M | $ 17M | $ 9M |
| 2013 | $ 91M | $ 10M | $ 22M |
| 2012 | $ 82M | $ 17M | $ 74M |
| 2011 | $ 77M | $ 15M | $ 71M |
| 2010 | $ 89M | $ 60M | $ 58M |
| 2009 | $ 125M | $ 11M | $ 6M |
| 2008 | $ 140M | -$ 77M | $ 5M |
| 2007 | $ 143M | -$ 35M | $ 8M |
| 2006 | $ 118M | $ 3M | $ 2M |
| 2005 | $ 98M | $ 5M | $ 9M |
| 2004 | $ 79M | $ 5M | $ 22M |
| 2003 | $ 65M | $ 5M | $ 20M |
| 2002 | $ 51M | $ 5M | $ 5M |
| 2001 | $ 37M | $ 1M | $ 5M |
| 2000 | $ 29M | $ 4M | $ 4M |
| 1999 | $ 26M | $ 4M | $ 3M |
| 1998 | $ 23M | $ 2M | $ 1M |
| 1997 | $ 16M | $ 1M | $ 2M |
| 1996 | $ 7M | -$ 900K | $ 4M |
| IPO1995 | $ 9M | -$ 800K | $ 7M |
Trinity Biotech plc fundamental performance
Between 2004 and 2024, revenue declined from $ 79M to $ 61M and net income went from $ 5M to -$ 31M. Revenue increased in 7 of those 20 years; net income in 9.
Across Trinity Biotech plc's full reported history, from 1995 to 2024, revenue grew from $ 9M to $ 61M and net income went from -$ 800K to -$ 31M. Revenue increased in 53% of the years measured; net income in 50%.
Trinity Biotech plc currently holds a 20-year HDB Score of 2.4 out of 10. How the HDB Score is calculated.
Membership
Continue TRIB’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
